Skip to main content
. 2021 Nov 2;22(21):11878. doi: 10.3390/ijms222111878
PI3K phosphatidylinositol-3 kinase
EGF epidermal growth factor
HR hormone receptor
ER estrogen receptor
LTED long-term estrogen deprivation
AI aromatase inhibitor
PFS progression free survival
AE adverse event
G grade
MBC metastatic breast cancer
MTD maximum tolerated dose